Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 2

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 2
---
 Pre-Funded Warrants to Purchase up to 1,949,317 Shares of Common Stock and up to 1,949,317 Shares of Common Stock Underlying the Pre-Funded Warrants Up to 7,797,268 Class H Common Stock Warrants to Purchase up to 7,797,268 Shares of Common Stock and up to 7,797,268 Shares of Common Stock Underlying the Class H Common Stock Warrants This is a best efforts public offering of up to 1,949,317 shares of our common stock and Class H warrants (the “Common Stock Warrants”) to purchase up to 7,797,268 shares of our common stock, at an assumed combined public offering price of $2.565 per share of common stock and accompanying Common Stock Warrants. The Common Stock Warrants will be exercisable beginning on the effective date of such stockholder approval as may be required by the applicable rules and regulations of the Nasdaq Capital Market (or any successor entity) to permit the exercise of the Common Stock Warrants (“Stockholder Approval”), Each Common Stock Warrant is exercisable at an exercise price of $ share and will expire five years from the initial exercise date. We are also offering to those purchasers, if any, whose purchase of common stock in this offering would otherwise result in any such purchaser, together with its affiliates, beneficially owning more than 4.99% (or, at the election of such purchaser, 9.99%) of our outstanding common stock immediately following the consummation of this offering, the opportunity to purchase pre-funded warrants in lieu of shares of our common stock that would otherwise result in such purchaser’s beneficial ownership exceeding 4.99% (or, at the election of such purchaser, 9.99%) of our outstanding common stock. The purchase price for each pre-funded warrant will equal the per share public offering price for the common stock in this offering less the $0.0001 per share exercise price of each such pre-funded warrant. Each pre-funded warrant will be exercisable upon issuance and will not expire prior to exercise. This prospectus also relates to the shares of common stock that are issuable from time to time upon exercise of the pre-funded warrants and Common Stock Warrants. Our common stock is quoted for trading on the Nasdaq Capital Market under the symbol “REVB”. On May 21, 2025, the last reported sales price for our common stock was $2.565 per share. The actual public offering price per